Morbimortalidad cardiopulmonar en pacientes con lupus eritematoso sistémico

Abstract

Patients with the diagnosis of systemic lupus erythematosus (SLE) have an elevated morbidity and mortality from cardiopulmonary complications that develop during the evolution of the disease. Considering the incidence of the mortality in this immunologic Cardiopulmonary morbidity and mortality in patients with systemic lupus erythematosus